Yet the sentiment ignores a large body of evidence demonstrating that Pgp expression in cancer is (1) a negative prognostic indicator; (2) associated with poor treatment efficacy; and (3) responsible for reduced levels of anticancer drugs in tumours. This evidence concerns the gene PGP and cancer.